Navigation Links
Lexicon to Present LX4211 Clinical and Preclinical Data at Diabetes Conference
Date:11/3/2011

THE WOODLANDS, Texas, Nov. 3, 2011 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering breakthrough treatments for human disease, announced today that Dr. David Powell, senior vice president of metabolism research, will present data from clinical and preclinical studies of LX4211, a dual inhibitor of sodium glucose transporters 1 and 2 (SGLT1 and SGLT2), at the Cambridge Healthtech Institute's Diabetes Drug Discovery conference in Boston, Massachusetts on Friday, November 4, 2011.

In clinical studies to date, LX4211 has demonstrated a favorable safety profile and beneficial effects on multiple parameters of glycemic control and cardiovascular health.  Recent studies in healthy subjects have shown that LX4211 substantially decreases postprandial glucose levels without hypoglycemia and substantially reduces triglycerides, results that have not been reported for SGLT2-selective inhibitors.  Data from a mechanistic study in patients with type 2 diabetes demonstrated that a single dose of LX4211 significantly increased circulating levels of GLP-1 (active and total) and PYY, important regulators of glycemic and appetite control.  In addition, postprandial release of GLP-1 and PYY from the gastrointestinal (GI) tract has been observed in preclinical studies of SGLT1 knockout mice but not in SGLT2 knockout mice, indicating that inhibition of SGLT1 function may trigger the postprandial release of these important regulators of glycemic and appetite control.

For more information on this program or to download a copy of the presentation, please visit www.lexpharma.com.

About Lexicon
Lexicon is a biopharmaceutical company focused on disco
'/>"/>

SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
2. Lexicon Reports Initial Clinical Trial Results for LX1031, an Investigational New Drug for Irritable Bowel Syndrome
3. Lexicon Files Investigational New Drug Application for LX2931 as a Potential Treatment for Rheumatoid Arthritis
4. Lexicon Initiates Phase 2a Trial of LX6171 Drug Candidate for Cognitive Disorders
5. Lexicon Presents Clinical Data on LX1032 for Carcinoid Syndrome at European Neuroendocrine Tumor Society Meeting
6. Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 First Quarter Results
7. Lexicons Drug Candidate LX1032 for Carcinoid Syndrome Receives Orphan Drug Designation From EMEA
8. Lexicon Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients With Type 2 Diabetes
9. Lexicon Announces Pricing of Common Stock in Public Offering
10. Lexicon Announces Completion of Public Offering of Common Stock
11. Lexicon Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... June 30, 2015  Today, the National Mobility Equipment ... 2015 National Mobility Awareness Month Local Heroes Contest on ... online entries that received 1.3 million votes. The sponsors ... Toyota Mobility , and Valley Honda Dealers ... and Vantage Mobility International (VMI) and ...
(Date:6/30/2015)... Calif. , June 30, 2015  Avanir ... PRISM II study showing that treatment with NUEDEXTA ... reduction in symptoms of pseudobulbar affect (PBA) in ... PBA is a distressing condition characterized by sudden ... from certain neurologic diseases or brain injury. PRISM ...
(Date:6/30/2015)... Minn. , June 30, 2015  EnteroMedics Inc. ... devices that use neuroblocking technology to treat obesity, metabolic ... its previously announced public offering  of 40,229,886 units. Each ... of a Series A warrant to purchase one share ... warrant to purchase one share of common stock, at ...
Breaking Medicine Technology:NMEDA Announces National Contest Winners 2NMEDA Announces National Contest Winners 3Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 2Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 3Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 4Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 5Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 6Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 7EnteroMedics Inc. Announces Pricing of $35.0 Million Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Pricing of $35.0 Million Public Offering of Common Stock and Warrants 3
(Date:6/30/2015)... ... 30, 2015 , ... When it comes to volunteering abroad, not many people ... will be too high. However, there are affordable programs to be had such as ... minimal cost. One such volunteer named Uzma Aishah, a student at the International Medical ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... and repair companies in San Diego. Bill Howe offers all employees ample opportunity ... several organizations, but most notably through the local Plumbing-Heating-Cooling-Contractors of San Diego (PHCC-SD). ...
(Date:6/30/2015)... ... 2015 , ... The Glenholme School graduated seventeen ... , The independent, coeducational, special needs boarding school began its eleventh commencement ... Center for the Arts. Along the way, the soon-to-be-graduates paused to observe the ...
(Date:6/30/2015)... ... June 30, 2015 , ... Lecrae is quickly developing into one ... Rolling Stone and The New York Times to Billboard Magazine and Variety, among others. ... of the many reasons why so many people are taking notice. , “We are ...
(Date:6/30/2015)... ... June 30, 2015 , ... The ... 28-31, 2015 at Disney’s Coronado Springs Resort in Lake Buena Vista, Florida, and ... year, this premiere event for psychiatric-mental health nursing draws more than 1,500 health ...
Breaking Medicine News(10 mins):Health News:Volunteers Transform Themselves and Their Resumes with Medical Volunteer Placements Abroad 2Health News:Volunteers Transform Themselves and Their Resumes with Medical Volunteer Placements Abroad 3Health News:Two Local San Diego Plumbers from Bill Howe Plumbing, Inc. Graduate from PHCC Academy 2Health News:Two Local San Diego Plumbers from Bill Howe Plumbing, Inc. Graduate from PHCC Academy 3Health News:The Glenholme School Graduates Its Class of 2015 2Health News:The Glenholme School Graduates Its Class of 2015 3Health News:The Glenholme School Graduates Its Class of 2015 4Health News:Hands of Hope to Present Grammy Award-Winner Lecrae in Concert this August 2Health News:Hands of Hope to Present Grammy Award-Winner Lecrae in Concert this August 3Health News:American Psychiatric Nurses Association 29th Annual Conference: Continuing Education and Collaboration in Psychiatric-Mental Health and Nursing 2Health News:American Psychiatric Nurses Association 29th Annual Conference: Continuing Education and Collaboration in Psychiatric-Mental Health and Nursing 3
... the top-selling class of drugs, known as atypical antipsychotic ... help, a study by researchers at the Stanford University ... Yet, drugs in this class may cause such serious ... cost Americans billions of dollars. "Because these drugs ...
... The ability to ride a bicycle can determine whether a ... in the Netherlands. Dr. Bastiaan R. Bloem and colleagues ... with Parkinson,s disease and 66 with atypical Parkinsonism. The patients ... Only two (4 percent) of those with regular Parkinson,s said ...
... JANUARY 6, 2011) NARSAD: The Brain and Behavior Research ... its investment in the most promising ideas to lead ... fourteen brilliant researchers from leading research institutions on six ... to receive Young Investigator grant awards to support their ...
... 6, 2011) According to a report published in the ... of Surgeons , surgery residents improved their knowledge of health ... Web-based curriculum. The expectation is for residents to "demonstrate ... system of health care, as well as the ability to ...
... time cancer seems to creep up gradually over time; cells ... sometimes cancers seem to pop up as if out of ... the journal Cell , a Cell Press publication, have ... the DNA sequences of multiple cancer samples of various types, ...
... on reactive oxygen species (ROS) ions or very small ... they damage cell structure and their potential link to stroke, ... Eli and Edythe Broad Center of Regenerative Medicine and Stem ... stem cells, the cells that give rise to neurons, maintain ...
Cached Medicine News:Health News:Evidence lacking for widespread use of costly antipsychotic drugs, says Stanford researcher 2Health News:Evidence lacking for widespread use of costly antipsychotic drugs, says Stanford researcher 3Health News:Evidence lacking for widespread use of costly antipsychotic drugs, says Stanford researcher 4Health News:NARSAD announces $12.6 million for new generation of brain and behavior research 2Health News:Web-based curriculum improves surgical residents' knowledge of health care business 2Health News:Cancer in a single catastrophe 2Health News:Neural stem cells maintain high levels of reactive oxygen species, UCLA study finds 2Health News:Neural stem cells maintain high levels of reactive oxygen species, UCLA study finds 3